Scoping Review: The Role of Psychedelics in the Management of Chronic Pain
Journal of Pain Research – March 01, 2024
Source: OpenAlex
Summary
Emerging evidence suggests psychedelics, including psilocybin, hold significant potential in medicine for alleviating chronic pain. This exciting area, explored via MEDLINE and Psychiatry databases, indicates hallucinogens derived from chemical synthesis and alkaloids could offer novel therapeutic avenues. While Complementary and Alternative Medicine Studies highlight promise, robust, randomized, double-blind, placebo-controlled trials are crucial. These Psychedelics and Drug Studies are essential to fully evaluate their role in chronic, non-cancer pain management.
Abstract
Psychedelics may have potential in alleviating pain symptoms secondary to a multitude of chronic pain conditions. However, further randomized, double-blind, placebo-controlled trials are needed to further explore and evaluate the role of psychedelics in chronic, non-cancer pain.